STAT

What if we’re no longer afraid of Ebola?

If we're no longer afraid of Ebola, we might have a problem.
A Ebola medical response worker checks her protective equipment in front of a mirror at the Bwera General Hospital in western Uganda.

In late July of 2014, I received an email from someone who had just started her medical residency. Why, she wanted to know, was the United States allowing American Dr. Kent Brantly to return to be treated for Ebola, which he had contracted while caring for patients in the exploding West African outbreak?

Why bring it here, she asked, expressing deep concern that his return could create an opportunity for Ebola to escape from Atlanta’s Emory University Hospital — where he was to be cared for in a special high containment unit — and spread on a continent where the virus is not typically found.

The email was a testament to a palpable sense of fear around in the Democratic Republic of the Congo isn’t getting much attention or much funding.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About FDA Oversight Of Shortages, AstraZeneca Threats, And More
Concerns have been raised over how the FDA maintains its list of drug shortages and which sources it relies on
STAT1 min read
STAT+: For This Cancer-focused Digital Health Startup, An FDA Rejection Meant The End Of The Road
Blue Note’s failure to clear the FDA hurdle offers a rare window into the regulatory challenges faced by digital therapeutics companies.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A New CVS Chief, Obesity Meds Cutting Overdoses, And More
CVS Health named David Joyner as its new chief, succeeding Karen Lynch at the helm of the struggling health care giant

Related Books & Audiobooks